Hivid

Zalcitabine (ddC) Hivid (anticipated discontinuation of distribution in 2006) 0.375-, 0.75-mg tab 0.75 mg tid CrCI Dose (mL/minute) 10-40 0.75 mg bid less than 10 0.75 mg qday No data on hemodialysis None Peripheral neuropathy stomatitis, lactic acidosis with hepatic steatosis (rare but potentially life-threatening toxicity with use of NRTIs) pancreatitis Renal excretion... [Pg.1262]

Zalcitabine (ddC, Hivid) is a cytidine analogue active against HIV-1, HIV-2, and hepatitis B virus. It is used for the treatment of HIV infection in adults and asymptomatic children as part of a multidrug regimen. It may be less effective than the other nucleoside inhibitors and is used less frequently. [Pg.588]

Hivid Zalcitabine 0.375, 0.75 mg Tablet HIV A synthetic nucleoside analog (DNA replacement) Lactose, MCC < croscarmellose Na, magnesium stearate, hypromellose, PEG, polysorbate 80 Roche... [Pg.17]

Zalcitabme/Hivid (ddC) 0.375 or 0.75 mg tablets 0.75mg t.i.d. Periphei al neuropatliy, lactic acidosis witli hepatic steatosis 0.08... [Pg.608]

Zagreb antivenom is a non-proprietary antivenom preparation that can be used as an injected ANTIDOTE to the poison from an adder s bite. However, the systemic allergic and other effects of the venom are rarely serious enough to warrant the use of the antivenom, zalcitabine [ban, inn, usan] (ddC DDC Hivid ) is a synthetic nucleoside analogue, a REVERSE TRANSCRIPTASE INHIBITOR which acts as an ANTIVIRAL AGENT. It is active orally as an ANTI-HIV AGENT. [Pg.294]

Synonyms ddC dideoxycytidine Trade name Hivid (Roche)... [Pg.620]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...